CHAD // Centre for Health Technology Assessment and Drug Research

2019
  • Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review

    Francisco Batel-Marques, Diogo Pereira, Diogo Mendes, Carlos Alves, Ana Penedones

    BMJ Open 2019;9:e032522. doi: 10.1136/bmjopen-2019-032522.

    2019

    + info
  • A comparison between two recommendations to conduct and report systematic reviews on drug’s safety.

    Penedones A, Alves C, Batel Marques F.

    Syst Rev. 2019 Oct 16;8(1):238. doi: 10.1186/s13643-019-1167-5. PubMed PMID: 31619279; PubMed Central PMCID: PMC6796334.

    2019

    + info
  • Risk of nonarteritic ischaemic opticneuropathy with phosphodiesterase type 5 inhibitors: a systematic review andmeta-analysis.

    Penedones A, Alves C, Batel Marques F.

    Acta Ophthalmol. 2019 Sep 27. doi: 10.1111/aos.14253. [Epub ahead of print] Review. PubMed PMID: 31559705.

    2019

    + info
  • A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs

    Ribeiro I, Batel Marques F, Alves D, Alves C.

    Expert Review of Pharmacoeconomics & Outcomes Research; DOI: 10.1080/14737167.2019.1579646

    2019

    + info
  • Prevalence of undiagnosed hypothyroidism in Europe: a systematic review and meta-analysis

    Mendes D, Alves C, Silverio N, Batel Marques F

    European Thyroid Journal doi: 10.1159/000499751

    2019

    + info
  • Intensive safety monitoring program of antineoplastic medicines: a pilot study in a Portuguese oncology hospital

    Mendes D, Rigueiro G, Silva R, Penedones A, Alves C, Sousa G, Batel Marques F

    Journal of Oncology Pharmacy Practice

    2019

    + info